CH510674A - Process for the preparation of salts of dihydro-orotic acid with primary, secondary or tertiary amines - Google Patents

Process for the preparation of salts of dihydro-orotic acid with primary, secondary or tertiary amines

Info

Publication number
CH510674A
CH510674A CH1891168A CH1891168A CH510674A CH 510674 A CH510674 A CH 510674A CH 1891168 A CH1891168 A CH 1891168A CH 1891168 A CH1891168 A CH 1891168A CH 510674 A CH510674 A CH 510674A
Authority
CH
Switzerland
Prior art keywords
dihydro
salts
primary
preparation
tertiary amines
Prior art date
Application number
CH1891168A
Other languages
German (de)
Inventor
Wilhelm Pfirrmann Rolf
Hofstetter Emil
Original Assignee
Geistlich Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag
Publication of CH510674A publication Critical patent/CH510674A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1891168A 1967-12-21 1968-12-19 Process for the preparation of salts of dihydro-orotic acid with primary, secondary or tertiary amines CH510674A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5814067A GB1182320A (en) 1967-12-21 1967-12-21 Dihydroorotic and Salts

Publications (1)

Publication Number Publication Date
CH510674A true CH510674A (en) 1971-07-31

Family

ID=10480857

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1891168A CH510674A (en) 1967-12-21 1968-12-19 Process for the preparation of salts of dihydro-orotic acid with primary, secondary or tertiary amines

Country Status (7)

Country Link
BE (1) BE725874A (en)
CH (1) CH510674A (en)
DE (1) DE1816097A1 (en)
ES (1) ES361702A1 (en)
FR (1) FR8234M (en)
GB (1) GB1182320A (en)
NL (1) NL6818217A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3912477A1 (en) * 1989-04-15 1990-10-18 Mueller Robert Dr OUTSTANDING PRAEPARATE AND ITS USE
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US6607735B2 (en) 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
US20040254202A1 (en) * 2003-06-13 2004-12-16 The Procter & Gamble Company Method of promoting sleep using topical administration of vasoactive agents

Also Published As

Publication number Publication date
DE1816097A1 (en) 1969-09-25
ES361702A1 (en) 1970-11-16
NL6818217A (en) 1969-06-24
FR8234M (en) 1970-09-28
GB1182320A (en) 1970-02-25
BE725874A (en) 1969-06-20

Similar Documents

Publication Publication Date Title
AT281778B (en) Process for the preparation of alk-3-en-1-ols
CH479559A (en) Process for the preparation of acylguanidines
CH489510A (en) Process for the preparation of substituted γ-triazoles
AT283594B (en) Process for the preparation of 7-halo-octopyranosides
AT279602B (en) Process for the preparation of pyrrol-3-yl-ketones
CH498142A (en) Process for the preparation of substituted piperidino-alkylthianaphthenes and -benzofurans
DE1772680B2 (en) METHOD FOR THE PHOTOGRAPHIC PRODUCTION OF MASKS
CH526524A (en) Process for the preparation of 6a, 6B-difluorosteroids
AT283357B (en) Process for the preparation of 2-aryl-v-triazoles
CH483425A (en) Process for the preparation of p-alkoxy-piperidine-amides
CH510674A (en) Process for the preparation of salts of dihydro-orotic acid with primary, secondary or tertiary amines
CH525173A (en) Process for the preparation of 3-methylbut-2-en-1-ol or 3-methylbut-2-en-1-ylacetate
CH507930A (en) Process for the preparation of 5-methyl-4-hydroxy-2,3-dihydrofuran-3-one
CH484930A (en) Process for the preparation of aryloxazoles
AT286293B (en) Process for the preparation of new styrylthiazolium salts
CH500935A (en) Process for the preparation of phenylsalicylic acid compounds
CH500232A (en) Process for the preparation of alkylthionophosphonic acid dichlorides
AT281420B (en) Process for the preparation of α-triorganosiloxy-ω-hydroxy-diorganopolysiloxanes
AT289295B (en) Process for the preparation of water-soluble salts of α-aminobenzylpenicilin
CH503765A (en) Process for the preparation of dihalides of halovinylphosphorous acid
CH493552A (en) Process for the preparation of 3-oxo-5-chloro-1,2,4-thiadiazolinium salts
AT282603B (en) Process for the preparation of hydroxybenzonitriles
AT281007B (en) Process for the preparation of hydroxybenzonitriles
AT280309B (en) Process for the preparation of 3-methanesulfonylphenthiazines
CH431542A (en) Process for the preparation of mercapto-pyridazine-N-oxides or their salts

Legal Events

Date Code Title Description
PL Patent ceased